Format

Send to

Choose Destination
See comment in PubMed Commons below
Virology. 2013 Jan 5;435(1):29-36. doi: 10.1016/j.virol.2012.10.006.

Varicella zoster vaccines and their implications for development of HSV vaccines.

Author information

1
Department of Pediatrics, Columbia University College of Physicians and Surgeons, NY, NY 10032, USA. aag1@columbia.edu

Abstract

Live attenuated vaccines to prevent varicella and zoster have been available in the US for the past 17 years, with a resultant dramatic decrease in varicella incidence and a predicted future decrease in the incidence of zoster. The pathogenesis and immune responses to varicella zoster virus (VZV) as well as the safety and effectiveness of VZV vaccines are reviewed. The lack of sterilizing immunity provided by VZV vaccines has not prevented them from being safe and effective. Virological and pathological information concerning parallels and differences between VZV and herpes simplex virus (HSV) are highlighted. Although VZV and HSV are distinct pathogens, they appear to have similarities in target organs and immunity that provide an expectation of a high likelihood for the success of vaccination against HSV, and predicted to be similar to that of VZV.

PMID:
23217613
PMCID:
PMC3595154
DOI:
10.1016/j.virol.2012.10.006
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center